Comprehensive analysis of Bank of India Small Cap Fund (IDCW) (38824) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Bank of India Investment Managers Private Ltd
The investment objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity-related securities of small cap companies. However, there can be no assurance that the investment objectives of the Scheme will be realized.
A comprehensive at-a-glance view of key mutual fund health indicators
Moderate Returns
High Risk
Moderate Expenses
Equity Focused
Seasoned Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Historical performance consistency
Market exposure level
Outperformance vs benchmark
Recent performance momentum
Fund manager experience
Assets under management
Risk-adjusted returns
Fund management costs
This fund has underperformed its benchmark by 3.68% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Industry | % Assets |
|---|---|---|
| TREPS | Debt Others | 5.15% |
| Reverse Repo | Debt Others | 3.72% |
| Lloyds Metals & Energy Ltd | Mining & Mineral products | 3.54% |
| Lloyds Metals & Energy Ltd | Mining & Mineral products | 3.30% |
| Quality Power Electrical Equipments Ltd | Capital Goods - Electrical Equipment | 2.92% |
| Quality Power Electrical Equipments Ltd | Capital Goods - Electrical Equipment | 2.87% |
| TREPS | Debt Others | 2.67% |
| Acutaas Chemicals Ltd | Pharmaceuticals | 2.57% |
| CreditAccess Grameen Ltd | Finance | 2.53% |
| ERIS Lifesciences Ltd | Pharmaceuticals | 2.51% |
Compare against Small Cap Fund category average
This comparison shows how the fund performs relative to the Small Cap Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Small Cap Fund category
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| Kotak Small Cap Fund - Direct (G) | ₹311.62 | -3.54% | 0.79% | 23.44% |
| Sundaram Small Cap Fund - Direct (G) | ₹288.19 | 0.88% | 4.76% | 27.70% |
| Quant Small Cap Fund - Direct (G) | ₹283.40 | 0.61% | -1.60% | 33.21% |
| Kotak Small Cap Fund (G) | ₹265.71 | -4.07% | -0.34% | 21.96% |
| Quant Small Cap Fund - (G) | ₹260.96 | 0.14% | -2.53% | 31.76% |
| Sundaram Small Cap Fund (G) | ₹260.46 | 0.35% | 3.63% | 26.28% |
| Quant Small Cap Fund - Direct (IDCW) | ₹221.53 | 0.61% | -1.60% | 33.22% |
| DSP Small Cap Fund - Direct (G) | ₹220.52 | -0.02% | 8.58% | 27.48% |
| Quant Small Cap Fund - (IDCW) | ₹207.53 | 0.14% | -2.53% | 31.78% |
| DSP Small Cap Fund (G) | ₹200.79 | -0.46% | 7.62% | 26.36% |
A seasoned investment professional with over 7 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.